Sponsor-Patient Interactions: Establishing Consensus on Good Practices for Patient Engagement in Drug Development

Thursday, June 15, 2017 10:00 AM to 04:00 PM

The National Health Council (NHC), in partnership with the Genetic Alliance (GA) and Food and Drug Law Institute (FDLI), is hosting a conference on good practices for sponsor-patient interactions as part of achieving meaningful patient engagement in drug development with a goal of establishing recommendations to inform company and patient advocacy group policy. Register.